WuXi XDC partners with IntoCell to accelerate ADC discovery and development
IntoCell will provide proprietary drug-linker technologies using their Ortho-Hydroxy Protected Aryl Sulfate
IntoCell will provide proprietary drug-linker technologies using their Ortho-Hydroxy Protected Aryl Sulfate
The company expects that this development could improve the strength of its application to the FDA for new drug approval
Multi-million dollar investment augments in-vitro biology capabilities in primary and secondary screening
The combination will support clients in getting their end-to-end discovery and development programs delivered.
The new company will utilize Teijin's drug discovery research technologies, facilities, equipment and personnel.
The JUMP-CP Consortium’s aim is to validate and scale up image-based drug discovery strategies by creating the world’s largest public cell imaging data set
The WAVEsystem with the WAVEcontrol 4.0 embedded
An outlay of Rs. 1,500 crore has been approved for strengthening/ up-gradation of these NIPERs for the period 2021-22 to 2025-26.
The partnership aims to enhance HotSpot's drug discovery and development efforts by incorporating GOSTAR's high-quality, annotated datasets into HotSpot's machine learning (ML) and artificial intelligence (AI) models
Subscribe To Our Newsletter & Stay Updated